DL-Norvaline
DL-Norvaline, a derivative of L-norvaline, L-norvaline is a non-competitive inhibitor of arginase.
Product Specifications
CAS Number
760-78-1
Product Name Alternative
2-Aminopentanoic acid
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Arginase; Endogenous Metabolite
Type
Natural Products
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/DL-Norvaline.html
Purity
98.0
Solubility
10 mM in DMSO|H2O : 50 mg/mL (ultrasonic)
Smiles
CCCC(N)C(O)=O
Molecular Formula
C5H11NO2
Molecular Weight
117.15
Precautions
H302, H315, H319, H335
References & Citations
[1]Sosroseno W, et al. Arginase activity in a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol. 2006 Jun;21 (3) :145-50.|[2]El-Bassossy HM, et al. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascul Pharmacol. 2012 Nov-Dec;57 (5-6) :194-200.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
